These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26408673)

  • 21. Clinical roundtable monograph: unmet needs in the treatment of chronic lymphocytic leukemia: integrating a targeted approach.
    O'Brien SM; Furman RR; Byrd JC; Smith A
    Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 3):1-13. PubMed ID: 24870382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab in chronic lymphocytic leukemia.
    Jaglowski SM; Byrd JC
    Semin Hematol; 2010 Apr; 47(2):156-69. PubMed ID: 20350663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising therapies for the treatment of chronic lymphocytic leukemia.
    Morabito F; Recchia AG; Vigna E; De Stefano L; Bossio S; Morabito L; Pellicanò M; Palummo A; Storino F; Caruso N; Gentile M
    Expert Opin Investig Drugs; 2015 Jun; 24(6):795-807. PubMed ID: 25728009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of advanced chronic lymphocytic leukemia.
    Cao TM; Coutre SE
    Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in the treatment of elderly/unfit chronic lymphocytic leukemia patients: results of the German CLL-11 trial.
    Molica S
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):9-15. PubMed ID: 25479582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Individualized Treatment of Chronic Lymphocytic Leukemia (CLL)].
    von Tresckow J; Hallek M; Eichhorst B
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1318-1324. PubMed ID: 30199912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New oral small molecules in the treatment of chronic lymphocytic leukemia.
    Lamanna N
    Cancer; 2015 Jun; 121(12):1917-26. PubMed ID: 25690403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Litchy S; Barton JH; Houston GA; Hermann RC; Bradof JE; Greco FA;
    J Clin Oncol; 2003 May; 21(9):1746-51. PubMed ID: 12721250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.
    Zelenetz AD; Gordon LI; Wierda WG; Abramson JS; Advani RH; Andreadis CB; Bartlett N; Byrd JC; Czuczman MS; Fayad LE; Fisher RI; Glenn MJ; Habermann TM; Harris NL; Hoppe RT; Horwitz SM; Kelsey CR; Kim YH; Krivacic S; LaCasce AS; Nademanee A; Porcu P; Press O; Rabinovitch R; Reddy N; Reid E; Saad AA; Sokol L; Swinnen LJ; Tsien C; Vose JM; Wilson L; Yahalom J; Zafar N; Dwyer M; Sundar H;
    J Natl Compr Canc Netw; 2015 Mar; 13(3):326-62. PubMed ID: 25736010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolving treatment landscape of chronic lymphocytic leukemia.
    Schiattone L; Ghia P; Scarfò L
    Curr Opin Oncol; 2019 Nov; 31(6):568-573. PubMed ID: 31593975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.
    Hallek M
    Am J Hematol; 2013 Sep; 88(9):803-16. PubMed ID: 23720127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of monoclonal antibody therapy for chronic lymphocytic leukemia.
    Nabhan C; Dyer MJ; Rosen ST
    Oncology (Williston Park); 2003 Feb; 17(2):253-62; discussion 264, 267, passim. PubMed ID: 12632866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early intervention in asymptomatic chronic lymphocytic leukemia.
    Muchtar E; Kay NE; Parikh SA
    Clin Adv Hematol Oncol; 2021 Feb; 19(2):92-103. PubMed ID: 33596191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphocytic leukemia: a clinical review.
    Nabhan C; Rosen ST
    JAMA; 2014 Dec; 312(21):2265-76. PubMed ID: 25461996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Therapy of CLL.
    Al-Sawaf O; Fischer K; Eichhorst B; Hallek M
    Oncol Res Treat; 2016; 39(12):768-778. PubMed ID: 27889784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel therapies for chronic lymphocytic leukemia in the 21st century.
    Byrd JC; Waselenko JK; Keating M; Rai K; Grever MR
    Semin Oncol; 2000 Oct; 27(5):587-97. PubMed ID: 11049025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular targeted therapy in lymphoid leukemias].
    Kojima K; Ando T; Kimura S
    Nihon Rinsho; 2014 Jun; 72(6):1094-8. PubMed ID: 25016810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy.
    Nastoupil LJ; Sinha R; Flowers CR
    Expert Rev Anticancer Ther; 2013 Sep; 13(9):1089-108. PubMed ID: 23919536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updates to the management of chronic lymphocytic leukemia.
    Wierda WG
    J Natl Compr Canc Netw; 2015 May; 13(5 Suppl):662-5. PubMed ID: 25995424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.